Amyloid-β Effects on Peripheral Nerve: A New Model System

Author:

Stecker Mark M.1ORCID,Srivastava Ankita2,Reiss Allison B.2ORCID

Affiliation:

1. Fresno Institute of Neuroscience, Fresno, CA 93730, USA

2. Department of Medicine and Biomedical Research Institute, NYU Grossman Long Island School of Medicine, Long Island, NY 11501, USA

Abstract

Although there are many biochemical methods to measure amyloid-β (Aβ)42 concentration, one of the critical issues in the study of the effects of Aβ42 on the nervous system is a simple physiological measurement. The in vitro rat sciatic nerve model is employed and the nerve action potential (NAP) is quantified with different stimuli while exposed to different concentrations of Aβ42. Aβ42 predominantly reduces the NAP amplitude with minimal effects on other parameters except at low stimulus currents and short inter-stimulus intervals. The effects of Aβ42 are significantly concentration-dependent, with a maximum reduction in NAP amplitude at a concentration of 70 nM and smaller effects on the NAP amplitude at higher and lower concentrations. However, even physiologic concentrations in the range of 70 pM did reduce the NAP amplitude. The effects of Aβ42 became maximal 5–8 h after exposure and did not reverse during a 30 min washout period. The in vitro rat sciatic nerve model is sensitive to the effects of physiologic concentrations of Aβ42. These experiments suggest that the effect of Aβ42 is a very complex function of concentration that may be the result of amyloid-related changes in membrane properties or sodium channels.

Funder

Alzheimer’s Foundation of America Award

The Herb and Evelyn Abrams Family Amyloid Research Fund

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference76 articles.

1. Alzheimer’s disease and the amyloid-β peptide;Murphy;J. Alzheimers Dis.,2010

2. Amyloid-β: A crucial factor in Alzheimer’s disease;Sabermarouf;Med. Princ. Pract.,2015

3. Brain amyloid-β oligomers in ageing and Alzheimer’s disease;Lesne;Brain,2013

4. Alzheimer’s disease: Many failed trials, so where do we go from here?;Reiss;J. Investig. Med.,2020

5. Comparison of two methods for the analysis of CSF Aβ and tau in the diagnosis of Alzheimer’s disease;Faull;Am. J. Neurodegener. Dis.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3